Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/1998
11/25/1998EP0879814A1 Triaromatic compounds, compositions containing them and uses thereof
11/25/1998EP0879233A1 Chinoline and benzimidazole derivatives as bradykinin agonists
11/25/1998CN1200120A Piperazino derivatives as neurokinin antagonists
11/25/1998CN1199623A Application of sinomenine in the preparation of medicine for immunological eye diseases
11/24/1998US5840979 Useful in the treatment and prevention of diseases in which cell death occurs by apoptosis
11/24/1998US5840939 Derivatives of succinamide and their use as metalloproteinase inhibitors
11/24/1998US5840723 Quinoxaline derivatives for treating tinnitus
11/24/1998US5840701 Antiischemic agents and macomolecules
11/24/1998US5840538 Lgt
11/24/1998US5840054 Method for obstructing lacrimal canaliculi with infusable solution or dispersion
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051313A1 Remedies for dry eye
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/18/1998EP0878200A1 Therapeutic agent for ophthalmic diseases
11/18/1998EP0878197A1 Compositions containing difluprednate
11/18/1998EP0877743A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1998CN1199339A Aqueous eye drops contg. apafant as principal agent
11/18/1998CN1199336A Method to increase retinal blood flow
11/18/1998CN1199335A Pharmaceutical preparation contg. nimesulide for topical use
11/17/1998US5837723 Pharmaceutical composition useful for treating ophthalmological diseases
11/17/1998US5837713 Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
11/14/1998CA2237503A1 Compositions containing difluprednate
11/12/1998WO1998050073A1 Integrin ligand, human mindin
11/12/1998CA2289001A1 Novel heterocyclic compounds
11/11/1998EP0876817A1 Remedy for keratoconjunctival diseases
11/11/1998EP0876343A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
11/11/1998EP0687266B1 Heterocyclic compounds and their preparation and use
11/11/1998CN1198775A Recombinant c-proteinase and processes, methods and uses thereof
11/11/1998CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998CN1198741A Imidazole derivatives having affinity for alpha 2 receptors activity
11/11/1998CN1198667A Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis
11/10/1998US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998US5834470 Decongestants; bronchodilator and antisecretory and -tussive agents; side effect reduction
11/10/1998US5834469 Endothelin receptor antagonists
11/10/1998US5834010 Triacetin as a penetration enhancer for transdermal delivery of a basic drug
11/10/1998CA2161697C Method and means for inhibiting posterior capsule opacification
11/10/1998CA2114877C Preparation of carbonic anhydrase inhibitors
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998048839A1 Topical nasal antiinflammatory compositions
11/05/1998WO1998048805A1 Pharmaceutical composition for supressing type 2 helper t cell immune response
11/05/1998WO1998048803A1 Eyedrops
11/05/1998WO1998039293A3 13-thia prostaglandins for use in glaucoma therapy
11/05/1998WO1998034583A3 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
11/05/1998WO1998032863A3 Mammalian thioredoxin
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2281789A1 Topical nasal antiinflammatory compositions
11/04/1998EP0874849A1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
11/04/1998EP0874621A1 Pharmaceutical compositions
11/03/1998US5830915 Oral diseases; skin disorders; antiinflammatory agents
11/03/1998US5830913 Method for preventing or treating dry eye or disease caused therefrom
11/03/1998US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998CA2181929C Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker
10/1998
10/29/1998WO1998048055A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998WO1998048027A2 Materials and methods for treatment of retinal diseases
10/29/1998WO1998048009A2 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998WO1998048002A1 Use of nerve growth factor for the storage, culture or treatment of cornea
10/29/1998WO1998047879A1 Substituted phenyl derivatives, their preparation and use
10/29/1998WO1998047536A1 Controlled release of ophthalmic compositions
10/29/1998WO1998047515A1 THE USE OF α-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES
10/29/1998WO1998047511A1 Use of mizolastine for preparing a medicine for treating inflammation
10/29/1998WO1998047504A1 Preventives or remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
10/29/1998WO1998047501A1 Pharmaceutical preparation containing nimesulide for oral administration
10/29/1998CA2288272A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998CA2287887A1 The use of .alpha.-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
10/29/1998CA2287508A1 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998CA2287495A1 Materials and methods for treatment of retinal diseases
10/29/1998CA2286120A1 Preventives or remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
10/29/1998CA2285424A1 Substituted phenyl derivatives, their preparation and use
10/28/1998EP0874050A2 Integrin ligand ITGL-TSP
10/28/1998EP0873312A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998EP0716648B1 New 9-chloro-prostaglandin derivatives
10/28/1998EP0701565B1 New prednisolone derivates
10/28/1998EP0649418B1 7-(2-aminoethyl)-benzothiazolones
10/28/1998CN1197391A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
10/28/1998CN1196933A External-use drops for ear and its prepn. method
10/27/1998US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998US5827863 Pyrazole derivatives as angiotensin II antagonists
10/27/1998US5827702 Contacting an ocular cell with exogenous nucleic acid under conditions permissive for it uptake and expression; genetic engineering
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/24/1998CA2228743A1 Novel integrin ligand itgl-tsp
10/22/1998WO1998046746A1 Extracellular/epidermal growth factor like protein
10/22/1998WO1998046606A1 Novel compounds
10/22/1998WO1998046563A1 Metalloproteinase inhibitors
10/22/1998WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998WO1998046237A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998CA2286351A1 Extracellular/epidermal growth factor like protein
10/22/1998CA2286078A1 Novel compounds
10/22/1998CA2285950A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/21/1998EP0872236A1 Eye drops
10/21/1998EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof
10/21/1998EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
10/21/1998EP0871446A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye
10/21/1998EP0871443A1 Advanced glycation end-product intermediaries and post-amadori inhibition
10/21/1998EP0871439A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 531